Search results
Author(s):
Luca Testa
,
Azeem Latib
Added:
3 years ago
Leaflet motion abnormalities (LMAs) are a relatively new entity in the field of transcatheter aortic valves (TAVs).1–4 They can be associated with the thrombosis of the bioprosthesis (TAVT), often leading to dramatic clinical scenarios1 or, on the other hand, they can result in a hypoattenuated leaflet thickening (HALT) and/or reduced leaflet motion (RELM), both usually associated with gradients…
View more
Author(s):
Neil Ruparelia
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is now the accepted treatment option of choice for patients presenting with severe symptomatic aortic stenosis who are deemed to be inoperable or of high surgical risk.1,2 Short- and intermediate-term outcomes have been promising3–5 and with increasing institutional and operator experience combined with technological advancements there has been…
View more
Author(s):
Giuliano Costa
,
Enrico Criscione
,
Denise Todaro
,
et al
Added:
3 years ago
Aortic stenosis (AS) is one of the most common valvular diseases in developed countries and its prevalence is projected to increase over the next decade as the population ages.1,2 Transcatheter aortic valve implantation (TAVI) is an established alternative to surgery for treatment of patients with symptomatic, severe AS.3
As the latest multicentre trials have established the role of TAVI…
View more
Author(s):
Richard J Jabbour
,
Akihito Tanaka
,
Antonio Colombo
,
et al
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) has undoubtedly revolutionised the treatment of severe aortic stenosis and has become the preferred treatment option for patients at increased surgical risk.1,2 Although outcomes have improved and complications reduced over time, certain potentially catastrophic complications remain.3,4 Coronary obstruction has long been a feared complication and is…
View more
Anticoagulation after TAVI
Author(s):
Antonio Greco
,
Davide Capodanno
Added:
3 years ago
Article
Author(s):
Azfar Zaman
,
Bernard Prendergast
,
David Hildick-Smith
,
et al
Added:
11 months ago
Author(s):
Ren Jie Yao
,
Matheus Simonato
,
Danny Dvir
Added:
3 years ago
In the context of an ageing population, care for valvular disease is becoming an increasingly important field. A recent large-scale population-based study found the prevalence of valvular disease to be 8.5 % in the 65–74-year-old group and 13.2 % in those over 75 years. 1 While mechanical surgical valves are more durable, bioprosthetic valves are often used as they are less thrombogenic and do…
View more
Author(s):
Hassan MH Mohammed
,
Ahmed Farah
,
Bjoern Plicht
,
et al
Added:
1 year ago
Author(s):
Jolanta Siller-Matula
,
Mamas A Mamas
,
Kimberly Atianzar
,
et al
Added:
3 years ago
A substantial number of patients develop a subclinical leaflet thrombosis (SLT) after transcatheter aortic valve replacement (TAVR).
The thrombus forms on the leaflets, which can lead to valve dysfunction and possibly to early valve degeneration. Multidetector computed tomography is the most sensitive imaging technique at detecting SLT.
Patients on antiplatelet drugs are at higher risk to…
View more